Drug intelligence / Profile preview

Nuvio Poultry

Development stage: Unknown
Lead developer: MicroSintesis
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Peptides, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Nuvio Poultry is a microbiome-based veterinary product developed by MicroSintesis to support intestinal health and prevent disorders such as necrotic enteritis in poultry. The product contains bioactive peptides derived from the fermentation of specific bacteria, which function as quorum sensing inhibitors (QSIs). These peptides disrupt the chemical cell-to-cell communication used by pathogenic bacteria to coordinate virulence, effectively reducing their impact without killing them or altering the natural microbiome composition. Often referred to as a 'proteobiotic' or postbiotic, Nuvio Poultry is a water-soluble treatment administered during stressful production phases to maintain intestinal balance and reduce mortality.

Brand names: Nuvio Poultry
Other names: Nuvio

Beyond the preview

Go deeper on Nuvio Poultry.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuvio Poultry.

Explore the full profile